Close
Form 8-K Kiniksa Pharmaceuticals, For: Feb 28 Feb 28, 2024 07:35AM false 0001730430 0001730430 2024-02-28 2024-02-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

  

CURRENT REPORT

Pursuant to Section 13 or... (continue reading...)


Form 8-K Payoneer Global Inc. For: Feb 28 Feb 28, 2024 07:35AM 0001845815false0001845815us-gaap:WarrantMember2024-02-282024-02-280001845815us-gaap:CommonStockMember2024-02-282024-02-2800018458152024-02-282024-02-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 28, 2024

 

Payoneer Global Inc.

 

 

(Exact Name of Registrant as Specified in its Charter)

 

... (continue reading...)


Form 8-K Harpoon Therapeutics, For: Feb 28 Feb 28, 2024 07:35AM false 0001708493 0001708493 2024-02-28 2024-02-28

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 28, 2024

 

 

Harpoon Therapeutics, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-38800   47-3458693 (State or Other... (continue reading...)
Form 10-K Immunocore Holdings plc For: Dec 31 Feb 28, 2024 07:34AM ... (continue reading...)
Form 10-K EMCOR Group, Inc. For: Dec 31 Feb 28, 2024 07:34AM 000010563412/312023FYfalse5,900,000,0001111111At the Company’s election, borrowings under the 2023 Revolving Credit Facility bear interest at either: (1) a base rate plus a margin of 0.125% to 0.875%, based on certain financial tests, or (2) a rate equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York for the applicable tenor plus 0.10% (“Adjusted Term SOFR”) plus a margin of 1.125% to 1.875%, based on certain financial... (continue reading...)

More SEC Filings

View Older Stories

Feb 28, 2024 07:33AM Form 144 MGP INGREDIENTS INC Filed by: Seaberg Karen
Feb 28, 2024 07:32AM Form 8-K Holley Inc. For: Feb 28
Feb 28, 2024 07:32AM Form 424B5 Easterly Government Prop
Feb 28, 2024 07:32AM Form 6-K Nayax Ltd. For: Feb 28
Feb 28, 2024 07:32AM Form 10-K Dine Brands Global, Inc. For: Dec 31
Feb 28, 2024 07:31AM Form 10-K NOVAVAX INC For: Dec 31
Feb 28, 2024 07:31AM Form C Target Arm Inc.
Feb 28, 2024 07:31AM Form 8-K Sensei Biotherapeutics, For: Feb 28
Feb 28, 2024 07:31AM Form 8-K/A Texas Pacific Land Corp For: Feb 27
Feb 28, 2024 07:31AM Form 6-K Perfect Corp. For: Feb 28
Feb 28, 2024 07:30AM Form 8-K AMERICAN FINANCIAL GROUP For: Feb 27
Feb 28, 2024 07:30AM Form 6-K Nayax Ltd. For: Feb 28
Feb 28, 2024 07:30AM Form 4 COMFORT SYSTEMS USA INC For: Feb 26 Filed by: Tang Vance W
Feb 28, 2024 07:30AM Form 4 COMFORT SYSTEMS USA INC For: Feb 26 Filed by: Trent T McKenna
Feb 28, 2024 07:30AM Form 4 COMFORT SYSTEMS USA INC For: Feb 26 Filed by: Mercado, Pablo G.
Feb 28, 2024 07:30AM Form 4 COMFORT SYSTEMS USA INC For: Feb 26 Filed by: GEORGE WILLIAM III
Feb 28, 2024 07:30AM Form 8-K LINDBLAD EXPEDITIONS For: Feb 28
Feb 28, 2024 07:27AM Form 497J DIAMOND HILL FUNDS
Feb 28, 2024 07:27AM Form 8-K Apartment Income REIT For: Feb 28
Feb 28, 2024 07:26AM Form 8-K Nautilus Biotechnology, For: Feb 28
Feb 28, 2024 07:26AM Form S-3 Nautilus Biotechnology,
Feb 28, 2024 07:25AM Form 8-K TG THERAPEUTICS, INC. For: Feb 28
Feb 28, 2024 07:22AM Form 10-K RYAN SPECIALTY HOLDINGS, For: Dec 31
Feb 28, 2024 07:21AM Form 8-K GERON CORP For: Feb 28
Feb 28, 2024 07:21AM Form 10-K Mind Medicine (MindMed) For: Dec 31
Feb 28, 2024 07:18AM Form 10-K Endeavor Group Holdings, For: Dec 31
Feb 28, 2024 07:16AM Form 6-K TCTM Kids IT Education For: Feb 28
Feb 28, 2024 07:16AM Form 144 MGP INGREDIENTS INC Filed by: Seaberg Karen
Feb 28, 2024 07:17AM Form 10-K Repare Therapeutics Inc. For: Dec 31
Feb 28, 2024 07:15AM Form 8-K Mind Medicine (MindMed) For: Feb 28
Feb 28, 2024 07:16AM Form S-8 Nautilus Biotechnology,
Feb 28, 2024 07:14AM Form 8-K Vita Coco Company, Inc. For: Feb 28
Feb 28, 2024 07:12AM Form 424B5 Easterly Government Prop
Feb 28, 2024 07:11AM Form 8-K Endeavor Group Holdings, For: Feb 28
Feb 28, 2024 07:10AM Form 8-K Repare Therapeutics Inc. For: Feb 28
Feb 28, 2024 07:10AM Form 8-K 1stdibs.com, Inc. For: Feb 28
Feb 28, 2024 07:10AM Form 8-K MADRIGAL PHARMACEUTICALS For: Feb 22
Feb 28, 2024 07:10AM Form 424B2 BofA Finance LLC
Feb 28, 2024 07:09AM Form 8-K NEXSTAR MEDIA GROUP, For: Feb 28
Feb 28, 2024 07:09AM Form 8-K Fulgent Genetics, Inc. For: Feb 28
Feb 28, 2024 07:08AM Form 6-K BioLineRx Ltd. For: Feb 28
Feb 28, 2024 07:08AM Form 8-K Veradigm Inc. For: Feb 27
Feb 28, 2024 07:08AM Form 8-K Mersana Therapeutics, For: Feb 28
Feb 28, 2024 07:07AM Form 10-D WFRBS Commercial Mortgag For: Feb 16
Feb 28, 2024 07:07AM Form 6-K KONINKLIJKE PHILIPS NV For: Feb 28
Feb 28, 2024 07:07AM Form 8-K Editas Medicine, Inc. For: Feb 28
Feb 28, 2024 07:07AM Form 6-K Can-Fite BioPharma Ltd. For: Feb 28
Feb 28, 2024 07:06AM Form 8-K BlackSky Technology Inc. For: Feb 28
Feb 28, 2024 07:06AM Form 8-K Vistra Corp. For: Feb 28
Feb 28, 2024 07:06AM Form S-8 Compass, Inc.
View Older Stories